Posts tagged “UNC-CH”

October 19, 2016

Premium Lock NC Biotech Center awarded more than $1M in loans and awards in Q1

NC Biotech Center The North Carolina Biotechnology Center awarded 17 grants and loans totaling $1,060,352 to companies, universities and nonprofit organizations across the state during the first quarter of its 2016-2017 fiscal year ending September 30.

September 2, 2016

Premium Lock A Labor Day salute to the talented UNC staff for NC Biz News Wire

NC Business News Wire WTW readers have no doubt noticed in the past few weeks a growing number of good stories from the North Carolina Business News Wire staff. And what better weekend to say "thank you" on behalf of WRAL TechWire while also introducing readers to a fine team of promising journalists at UNC-Chapel Hill.

August 22, 2016

Premium Lock RTP's curasan sees growth in bones for regenerative medicine firm

Shane Ray, curasan Inc. president Veteran health care entrepreneur Shane Ray has skin in the tissue regeneration game and he sees growth in bones for RTP-based curasan.

August 4, 2016

Premium Lock From virtual startup to a $645M reality: The Bamboo Therapeutics story

What a year 2016 has turned out to be for Chapel Hill life science startup Bamboo Therapeutics. From a Papal blessing in January to a $50 million capital fund raise in February to the $150 million acquisition announced Monday (and up to $495 million more to come). NC Biotech Writer Barry Teater writes about the deal and provides the backstory on Bamboo's history.

A papal blessing A papal blessing

July 22, 2016

Premium Lock MCNC revenue grows, sets goal of all time high broadband connectivity

MCNC MCNC, the non-profit operator of the North Carolina Research and Education Network (NCREN), says that as it starts a new fiscal year with growing revenue and employee base it is ready to bring broadband connectivity levels in the state to all-time highs.

Updated July 21, 2016

Premium Lock NC Biotech Center awarded $2.5M to universities and companies

Biotechnology  The North Carolina Biotechnology Center awarded 36 loans and grants totaling nearly $2.5 million to universities and bioscience companies during the fourth quarter of its 2015-2016 fiscal year ending June 30.

June 10, 2016

Premium Lock UNC-CH spinout BioFluidica lands $2M in financing

Venture funding BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection. has completed a $2 million Series A funding round.

May 31, 2016

Premium Lock Duke, UNC researchers to use drones to find sharks

Drones could detect sharks underwater Drones just may help keep you safer from sharks on a future visit to the beach thanks to efforts by researchers at UNC-Chapel Hill and Duke.

Updated May 20, 2016

Premium Lock Moogfest: How close are we to a holodeck?

What is the next step in virtual reality technology? It's "mixed reality," the merger of virtual reality with the real world, according to R. Benjamin Knapp, PhD, director of the Institute for Creativity, Arts, and Technology (ICAT) at Virginia Tech during the "How Close Can We Get to a Holodeck event at Moog fest Friday morning.

R. Benjamin Knapp talks future tech R. Benjamin Knapp talks future tech

Updated May 19, 2016

Premium Lock Joe DeSimone's thrilling day: 'Wow. Humbling'

The medal has been delivered - Dr. Joseph DeSimone is one happy man. The inventor, professor, entrepreneur received the National Medal of Technology and Innovation from President Obama on Thursday in a White House ceremony, and his response when asked beforehand if he was excited he replied: "Are you kidding me? THRILLED!" By the way, he also had some ideas on innovation to share with the President. Later, he tweets: "Wow. Humbling."

Dr. Joseph DeSimone receives his medal from President Obama Dr. Joseph DeSimone receives his medal from President Obama

May 12, 2016

Premium Lock Triangle headlines: TransEnterix job cuts; G1 raises $47M; UNC-NCSU biomed eningeering effort

Triangle headlines In a wrapup of technology and life science news being reported by Triangle media outlets: TransEnterix cuts jobs after FDA rejects robot; G1 Therapeutics adds to a big fundraiser; and a look at the joint UNC-NCSU biomedical engineering effort.

April 11, 2016

Premium Lock UNC-CH seniors' app wins $10K in 'real world' money

A team of UNC seniors wins the annual startup pitch competition at UNC-Chapel Hill and $10,000 with their Unisource app. ExitEvent's Edgar Walker reports.

Unisource winners Unisource winners

Updated March 24, 2016

Premium Lock SAS No. 6, Duke U. No. 14 on Forbes' best employers list

Forbes  SAS and Duke University are two of the nation's top large company employers in the U.S., according to a new report from Forbes magazine. UNC-Chapel Hill also makes the list.

March 4, 2016

Premium Lock Hatteras Ventures to invest $10M in UNC startups

Michael Dial Hatteras Ventures, a $350 million venture capital firm in Durham, says it will invest up to $10 million in startups linked to UNC-Chapel Hill. As part of the agreement, Hatteras will manage UNC's Carolina Research Ventures investment fund.

Updated March 2, 2016

Premium Lock 4 universities form Triangle Venture Alliance to fund startups

Venture Capital     Boosted by a $250,000 federal grant, four Triangle Universities are forming the Triangle Venture Alliance which plans to work with alumni in funding startups. The alliance is the second major boost to emerging ventures in the Triangle in two days, NCSU having announced a new $1M fund and accelerator as well on Tuesday.

February 23, 2016

Premium Lock UNC-CH names geneticist professor as new research leader

Dr. Terry Magnuson, a professor and geneticist researcher, will become the new vice chancellor for research at UNC-Chapel Hill on July 1. He will replace Dr. Barbara Entwisle.

Dr. Terry Magnuson Dr. Terry Magnuson

February 22, 2016

Premium Lock GSK wraps up $1.46B HIV drug pipeline deal with Bristol-Myers Squibb

GSK's HQ in London               GlaxoSmithKline is boosting its own efforts to fight AIDS by closing on a deal to buy the HIV drug pipeline of Bristol-Myers Squibb . The transaction is worth as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.

Updated February 12, 2016

Premium Lock After papal blessing, Chapel Hill gene therapy startup raises nearly $50M

Answered prayers? Recently blessed for its work by the Pope, Bamboo Therapeutics, a recently launched life sciences venture focusing on gene therapy to treat deadly childhood neurological disorders, has raised nearly $50 million from investors. CureDuchenne Ventures LLC, a venture philanthropy organization, is among the backers.

Sheila Mikhail Sheila Mikhail

February 2, 2016

Premium Lock Gene editing: As Britain OKs research, what are the facts?

Britain's decision to allow researchers to edit the genes of human embryos -- not to create babies but to start unraveling the earliest stages of development -- is raising new questions about the ethics of this hot new technology.

A nanoscale machine targets DNA A nanoscale machine targets DNA

January 27, 2016

Premium Lock How can NC create more STEM jobs? A UNC-CH exec offers insight

STEM News WalletHub published a report this week that says Raleigh ranks 14th among the nation's top 100 metro areas for STEM-related jobs. In a Q&A, WalletHub talked with Jeff Sackaroff, associated director of career services at UNC-Chapel Hill, about how areas can improve the STEM job environment and also attract more minorities as well as women.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith